ArticleBMC neurology2025
Neuronal intranuclear inclusion disease with recurrent encephalitis.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Adult-onset neuronal intranuclear inclusion disease initially presenting with prominent gastrointestinal symptoms: a case report.BMC neurology · 2026Article
- Neuronal Intranuclear Inclusion Disease: A Case Report With Insights Into Clinical Features and Potential Therapeutic Implications.Case reports in neurological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuronal intranuclear inclusion disease (NIID) is a progressive neurodegenerative disorder characterized by eosinophilic intranuclear inclusions in neurons and multiple visceral organs, leading to heterogeneous clinical manifestations. This case report presents two rare NIID patients with recurrent encephalitis-like episodes, periodic prolonged hospitalizations, mimicking mitochondrial encephalomyopathies. CASE PRESENTATION: The first patient was a 63-year-old man with a history of migraines, who experienced two episodes of acute fever, headache, motor aphasia, behavioral abnormalities, seizures, and stroke-like symptoms over a period of four years. Brain MRI revealed swelling in the temporo-occipital lobe. Cerebrospinal fluid analysis demonstrated elevated protein levels, while tests for autoimmune encephalitis antibodies and mitochondrial gene mutations were negative. The second patient was a 38-year-old man with a family history of consanguinity, who presented with recurrent episodes of fever, limb weakness, aphasia, and psychiatric disturbances, occurring numerous times over five years. A recent MRI showed swelling in the left temporo-occipital lobe, dot-like high signals in the right frontal-parietal-temporal lobe, and filamentous high signals at the corticomedullary junction. Genetic testing revealed 93 and 101 GGC repeats, respectively, in the 5' untranslated region (5' UTR) of the NOTCH2NLC gene, indicating abnormal expansion and confirming the diagnosis of NIID.
conclusionsThis report underscores the importance of recognizing NIID in patients with recurrent encephalitis-like presentations and highlights the diagnostic utility of genetic testing in distinguishing it from conditions like mitochondrial encephalopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.